Healthcare & Life Sciences
Forcefield Therapeutics
series-a
series-a
Stage
1
Investors
About
Forcefield Therapeutics develops biologic therapeutics to protect heart function by preventing or arresting the loss of cardiomyocytes following myocardial infarction, aiming to reduce progression to heart failure.
Explore Forcefield Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.